๐ŸŽ Black Friday: up to 50% off of annual plans
Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM ยท Real-Time Price ยท USD
2.970
+0.110 (3.85%)
At close: Nov 20, 2026, 4:00 PM EST
3.005
+0.035 (1.19%)
After-hours: Nov 20, 2026, 7:30 PM EST

Psyence Biomedical Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Income
-6.3-6.24-3.66-2.75-3.23-1.86
Net Income
-6.88-6.941.01-51.16-3.21-1.86
Earnings Per Share
-2.99-12.5632.76---
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
21.077.446.140.731.331.76
Total Debt
---10.45--
Net Cash (Debt)
21.077.446.14-9.711.331.76
Net Cash Growth
194.66%21.35%---23.97%-
Net Cash Per Share
9.1513.48198.63---

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-6.51-8.14-3.73-2.95-1.59-1.4
Capital Expenditures
-0-0-0.01-0.01--
Free Cash Flow
-6.51-8.14-3.74-2.95-1.59-1.4
Free Cash Flow Growth
------

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
--2.69---